Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Botulinum toxin type A (BoNT-A) is used to treat dystonia. The commonest form, cervical dystonia, is more common in women; since many are still of childbearing age,1 some women on botulinum toxin treatment inevitably will either be planning to become pregnant or may wish to be treated while pregnant. The use of BoNT-A for chronic migraine—a female-predominant disorder—will make botulinum treatment an increasingly common issue for women,2 leaving aside the use of BoNT-A in a cosmetic setting. To inform discussions with patients, clinicians need to understand the known …
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by Ralph Gregory, Poole, UK.
Read the full text or download the PDF:
Other content recommended for you
- Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia
- Botulinum toxin for writer’s cramp: a randomised, placebo-controlled trial and 1-year follow-up
- A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport® and Botox®in the treatment of cervical dystonia
- Botulinum toxin in clinical practice
- British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin
- Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy
- Effects of botulinum toxin type A on vibration induced facilitation of motor evoked potentials in spasmodic torticollis
- Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia
- Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervation
- What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport®